){kind=logo}
Long Live Protein: Where the Post-Hype Market is Moving
- As the protein category recalibrates, which segments are demonstrating sustained commercial traction, and where has demand structurally weakened?
- Where do formulators still face unmet challenges (in texture, emulsification, nutrition density, or stability), and who is meaningfully addressing them?
- With price volatility across traditional animal proteins, how are CPGs evaluating animal-free dairy and alternative eggs as long-term portfolio hedges rather than short-term disruption bets?
- Which next-generation protein formats (blended, hybrid, functional ingredients vs. finished analogues) are closest to solving real manufacturing constraints?
- As consolidation accelerates, where is capital flowing today, infrastructure, B2B ingredients, enabling technologies, and what does that signal about the sector’s next phase?